emerging data in egfr-mutant lung cancer
Published 7 years ago • 564 plays • Length 7:08Download video MP4
Download video MP3
Similar videos
-
1:01
dr. shum on emerging targeted therapies in egfr-mutant nsclc
-
37:44
deciphering the data in egfr - mutant nsclc
-
3:28
treating beyond progression in egfr-mutant lung cancer
-
0:59
dr. west on emerging changes in the field of egfr-mutant nsclc
-
5:02
egfr-mutant lung cancer: initial approach
-
9:39
emerging therapies in egfr-positive nsclc
-
6:57
egfr exon 20 mutations in non–small cell lung cancer
-
6:56
first-line therapy in the patient with egfr-mutant lung cancer
-
1:15
dr. aggarwal on triplet therapy in egfr-mutant lung cancer
-
58:47
15 years of advances in egfr mutant lung cancer
-
4:25
do immune checkpoint inhibitors work in egfr mutant lung cancer?
-
1:41
impower150 data for immunotherapy quadruplet in egfr-mutant lung cancer
-
1:18:11
management of egfr-mutant lung cancer with central nervous system metastases
-
3:38
overview of the world of egfr mutant lung cancers
-
1:02:40
new milestones and changing standards of care in early egfr-mutated nsclc
-
0:48
current role of immunotherapy in egfr-mutant lung cancer
-
1:12
dr. yorio on t-dm1 in her2-mutant lung cancer treatment
-
1:45
phase iii data support frontline osimertinib in egfr-mutant lung cancers
-
0:42
dr. fidler discusses osimertinib in egfr-mutated lung cancer